Abstract:There is a growing concern that neuroactive chemicals released into the environment can perturb wildlife behaviour. Among these chemicals, pharmaceuticals such as antidepressants and anxiolytics have been receiving increasing attention, as they are specifically prescribed to modify behavioural responses. Many laboratory studies have demonstrated that some of these compounds can affect various aspects of the behaviour of a range of aquatic organisms; however, these investigations are focused on a very small set of neuroactive pharmaceuticals, and they often consider one compound at a time. In this study, to better understand the environmental and toxicological dimension of the problem, we considered all pharmaceuticals explicitly intended to modulate the central nervous system (CNS), and we hypothesised that these compounds have higher probability of perturbing animal behaviour. Based on this hypothesis, we used the classification of pharmaceuticals provided by the British National Formulary (based on their clinical applications) and identified 210 different CNS-acting pharmaceuticals prescribed in the UK to treat a variety of CNS-related conditions, including mental health and sleep disorders, dementia, epilepsy, nausea, and pain. The analysis of existing databases revealed that 84 of these compounds were already detected in surface waters worldwide. Using a biological read-across approach based on the extrapolation of clinical data, we predicted that the concentration of 32 of these neuroactive pharmaceuticals in surface waters in England may be high enough to elicit pharmacological effects in wild fish. The ecotoxicological effects of the vast majority of these compounds are currently uncharacterised. Overall, these results highlight the importance of addressing this environmental challenge from a mixture toxicology and systems perspective. The knowledge platform developed in the present study can guide future region-specific prioritisation efforts, inform the design of mixture studies, and foster interdisciplinary efforts aimed at identifying novel approaches to predict and interpret the ecological implications of chemical-induced behaviour disruption.

Occurrence and fate of antidepressants in the aquatic environment: Insights into toxicological effects on the aquatic life, analytical methods, and removal techniques

Antidepressants As Emerging Contaminants: Occurrence in Wastewater Treatment Plants and Surface Waters in Hangzhou, China.

Antidepressants and COVID-19: Increased use, occurrence in water and effects and consequences on aquatic environment. A review

Pollution and Ecotoxicity of Antidepressants in Aquatic Environment

The potential for adverse effects in fish exposed to antidepressants in the aquatic environment

Antidepressants as Endocrine Disrupting Compounds in Fish

Biological-Activity-Based Prioritization of Antidepressants in Wastewater in England and Japan

Transformation Mechanisms of Antidepressants in Biological Wastewater Treatment: Removal Kinetic, Transformation Products and Pathways

Occurrence of antidepressant residues in the sewage-impacted Vistula and Utrata rivers and in tap water in Warsaw (Poland)

Environmental concerns and bioaccumulation of psychiatric drugs in water bodies - Conventional versus biocatalytic systems of mitigation

Antidepressants in Wastewater Treatment Plants: Occurrence, Transformation and Acute Toxicity Evaluation

Photodegradation of Three Antidepressants in Natural Waters: Important Roles of Dissolved Organic Matter and Nitrate.

Toxicity and bioaccumulation of selected antidepressants in Lemna minor (L.)

The effects of antidepressants appear to be rapid and at environmentally relevant concentrations

Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use

Predicting the potential risks posed by antidepressants as emerging contaminants in fish based on network pharmacological analysis

Integrated physio-biochemical and transcriptomic analysis reveals the joint toxicity mechanisms of two typical antidepressants fluoxetine and sertraline on Microcystis aeruginosa

Medicating the coast in a metropolitan city: Enantiomeric profiles and joint probabilistic risk assessment of antidepressants and antihistamines

Ultraviolet Oxidative Degradation of Typical Antidepressants: Pathway, Product Toxicity, and DFT Theoretical Calculation.

Pharmaceuticals in Water: Risks to Aquatic Life and Remediation Strategies

Trace analysis of 47 psychotropic medications in environmental samples by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS)